Structure

Physi-Chem Properties

Molecular Weight:  434.14
Volume:  391.788
LogP:  -1.567
LogD:  -1.671
LogS:  -0.854
# Rotatable Bonds:  6
TPSA:  198.76
# H-Bond Aceptor:  12
# H-Bond Donor:  8
# Rings:  3
# Heavy Atoms:  12

MedChem Properties

QED Drug-Likeness Score:  0.216
Synthetic Accessibility Score:  4.149
Fsp3:  0.667
Lipinski Rule-of-5:  Rejected
Pfizer Rule:  Accepted
GSK Rule:  Rejected
BMS Rule:  1
Golden Triangle Rule:  Accepted
Chelating Alert:  0
PAINS Alert:  0

ADMET Properties (ADMETlab2.0)

ADMET: Absorption

Caco-2 Permeability:  -6.45
MDCK Permeability:  8.949993934947997e-05
Pgp-inhibitor:  0.001
Pgp-substrate:  0.812
Human Intestinal Absorption (HIA):  0.903
20% Bioavailability (F20%):  0.008
30% Bioavailability (F30%):  0.998

ADMET: Distribution

Blood-Brain-Barrier Penetration (BBB):  0.192
Plasma Protein Binding (PPB):  28.691884994506836%
Volume Distribution (VD):  0.422
Pgp-substrate:  33.60203552246094%

ADMET: Metabolism

CYP1A2-inhibitor:  0.061
CYP1A2-substrate:  0.019
CYP2C19-inhibitor:  0.008
CYP2C19-substrate:  0.197
CYP2C9-inhibitor:  0.0
CYP2C9-substrate:  0.088
CYP2D6-inhibitor:  0.007
CYP2D6-substrate:  0.131
CYP3A4-inhibitor:  0.003
CYP3A4-substrate:  0.007

ADMET: Excretion

Clearance (CL):  1.015
Half-life (T1/2):  0.856

ADMET: Toxicity

hERG Blockers:  0.283
Human Hepatotoxicity (H-HT):  0.023
Drug-inuced Liver Injury (DILI):  0.052
AMES Toxicity:  0.108
Rat Oral Acute Toxicity:  0.018
Maximum Recommended Daily Dose:  0.0
Skin Sensitization:  0.155
Carcinogencity:  0.073
Eye Corrosion:  0.003
Eye Irritation:  0.039
Respiratory Toxicity:  0.01

Download Data

Data Type Select
General Info & Identifiers & Properties  
Structure MOL file  
Source Organisms  
Biological Activities  
Similar NPs/Drugs  

  Natural Product: NPC228907

Natural Product ID:  NPC228907
Common Name*:   Pyrocatechol-O-Beta-D-Diglucopyranoside
IUPAC Name:   (2R,3S,4S,5R,6S)-2-(hydroxymethyl)-6-[2-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyphenoxy]oxane-3,4,5-triol
Synonyms:  
Standard InCHIKey:  QWZXKMQLRBUBMH-NNUBVHJDSA-N
Standard InCHI:  InChI=1S/C18H26O12/c19-5-9-11(21)13(23)15(25)17(29-9)27-7-3-1-2-4-8(7)28-18-16(26)14(24)12(22)10(6-20)30-18/h1-4,9-26H,5-6H2/t9-,10-,11-,12-,13+,14+,15-,16-,17-,18-/m1/s1
SMILES:  c1ccc(c(c1)O[C@H]1[C@@H]([C@H]([C@@H]([C@@H](CO)O1)O)O)O)O[C@H]1[C@@H]([C@H]([C@@H]([C@@H](CO)O1)O)O)O
Synthetic Gene Cluster:   n.a.
ChEMBL Identifier:   CHEMBL512797
PubChem CID:   44577197
Chemical Classification**:  
  • CHEMONTID:0000000 [Organic compounds]
    • [CHEMONTID:0004603] Organic oxygen compounds
      • [CHEMONTID:0000323] Organooxygen compounds
        • [CHEMONTID:0000011] Carbohydrates and carbohydrate conjugates
          • [CHEMONTID:0002105] Glycosyl compounds
            • [CHEMONTID:0004165] Phenolic glycosides

*Note: the InCHIKey will be temporarily assigned as the "Common Name" if no IUPAC name or alternative short name is available.
**Note: the Chemical Classification was calculated by NPClassifier Version 1.5. Reference: PMID:34662515.

  Species Source

Organism ID Organism Name Taxonomy Level Family SuperKingdom Isolation Part Collection Location Collection Time Reference
NPO9317 Itoa orientalis Species Salicaceae Eukaryota bark, twigs, and leaves n.a. n.a. PMID[18412396]
NPO9317 Itoa orientalis Species Salicaceae Eukaryota n.a. n.a. n.a. Database[UNPD]

☑ Note for Reference:
In addition to directly collecting NP source organism data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated them from below databases:
UNPD: Universal Natural Products Database [PMID: 23638153].
StreptomeDB: a database of streptomycetes natural products [PMID: 33051671].
TM-MC: a database of medicinal materials and chemical compounds in Northeast Asian traditional medicine [PMID: 26156871].
TCM@Taiwan: a Traditional Chinese Medicine database [PMID: 21253603].
TCMID: a Traditional Chinese Medicine database [PMID: 29106634].
TCMSP: The traditional Chinese medicine systems pharmacology database and analysis platform [PMID: 24735618].
HerDing: a herb recommendation system to treat diseases using genes and chemicals [PMID: 26980517].
MetaboLights: a metabolomics database [PMID: 27010336].
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  NP Quantity Composition/Concentration

Organism ID NP ID Organism Material Preparation Organism Part NP Quantity (Standard) NP Quantity (Minimum) NP Quantity (Maximum) Quantity Unit Reference

☑ Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP quantitative records for specific NP domains (e.g., NPS from foods or herbs) from domain-specific databases. These databases include:
DUKE: Dr. Duke's Phytochemical and Ethnobotanical Databases.
PHENOL EXPLORER: is the first comprehensive database on polyphenol content in foods [PMID: 24103452], its homepage can be accessed at here.
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  Biological Activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference
NPT31 Individual Protein Cyclooxygenase-2 Homo sapiens Inhibition = 54.3 % PMID[469464]

☑ Note for Activity Records:
☉ The quantitative biological activities were primarily integrated from ChEMBL (Version-30) database and were also directly collected from PubMed literature. PubMed PMID was provided as the reference link for each activity record.

  Chemically structural similarity: I. Similar Active Natural Products in NPASS

Top-200 similar NPs were calculated against the active-NP-set (includes 4,3285 NPs with experimentally-derived bioactivity available in NPASS)

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient

●  The left chart: Distribution of similarity level between NPC228907 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.56 or Top200).

Similarity Score Similarity Level Natural Product ID
0.9402 High Similarity NPC25817
0.9381 High Similarity NPC9248
0.9316 High Similarity NPC217854
0.9244 High Similarity NPC298845
0.9167 High Similarity NPC37074
0.9091 High Similarity NPC247146
0.9083 High Similarity NPC189589
0.9083 High Similarity NPC469622
0.906 High Similarity NPC276195
0.8983 High Similarity NPC57751
0.8947 High Similarity NPC142319
0.8943 High Similarity NPC60756
0.8917 High Similarity NPC221090
0.8908 High Similarity NPC152722
0.8871 High Similarity NPC9912
0.8871 High Similarity NPC287780
0.8852 High Similarity NPC469621
0.8833 High Similarity NPC192810
0.879 High Similarity NPC208769
0.878 High Similarity NPC302378
0.877 High Similarity NPC171533
0.873 High Similarity NPC60982
0.871 High Similarity NPC248355
0.8661 High Similarity NPC87696
0.864 High Similarity NPC472024
0.864 High Similarity NPC80600
0.8594 High Similarity NPC470236
0.8583 High Similarity NPC469412
0.8583 High Similarity NPC198734
0.856 High Similarity NPC26653
0.856 High Similarity NPC270849
0.856 High Similarity NPC166040
0.8527 High Similarity NPC164857
0.8516 High Similarity NPC187194
0.8516 High Similarity NPC476411
0.8504 High Similarity NPC162093
0.85 High Similarity NPC469708
0.85 High Similarity NPC60589
0.8455 Intermediate Similarity NPC287429
0.8443 Intermediate Similarity NPC476142
0.8438 Intermediate Similarity NPC49074
0.8438 Intermediate Similarity NPC25821
0.843 Intermediate Similarity NPC269242
0.8425 Intermediate Similarity NPC166168
0.8413 Intermediate Similarity NPC307110
0.84 Intermediate Similarity NPC140750
0.8387 Intermediate Similarity NPC470510
0.8372 Intermediate Similarity NPC35731
0.8361 Intermediate Similarity NPC226712
0.8333 Intermediate Similarity NPC202700
0.8333 Intermediate Similarity NPC106944
0.8321 Intermediate Similarity NPC65530
0.8321 Intermediate Similarity NPC59324
0.8321 Intermediate Similarity NPC470413
0.8321 Intermediate Similarity NPC138738
0.832 Intermediate Similarity NPC233559
0.8308 Intermediate Similarity NPC55040
0.8295 Intermediate Similarity NPC215833
0.8295 Intermediate Similarity NPC69513
0.8281 Intermediate Similarity NPC65942
0.8281 Intermediate Similarity NPC248307
0.8268 Intermediate Similarity NPC295970
0.8258 Intermediate Similarity NPC212770
0.8258 Intermediate Similarity NPC98777
0.8244 Intermediate Similarity NPC104167
0.8244 Intermediate Similarity NPC37468
0.8244 Intermediate Similarity NPC242028
0.8244 Intermediate Similarity NPC203230
0.8231 Intermediate Similarity NPC48863
0.8231 Intermediate Similarity NPC13745
0.8231 Intermediate Similarity NPC251981
0.8217 Intermediate Similarity NPC299144
0.8217 Intermediate Similarity NPC252833
0.8203 Intermediate Similarity NPC470079
0.8189 Intermediate Similarity NPC198487
0.8182 Intermediate Similarity NPC304152
0.8154 Intermediate Similarity NPC132895
0.8154 Intermediate Similarity NPC6836
0.8134 Intermediate Similarity NPC76871
0.8134 Intermediate Similarity NPC469661
0.8125 Intermediate Similarity NPC218003
0.812 Intermediate Similarity NPC100389
0.8106 Intermediate Similarity NPC199459
0.8106 Intermediate Similarity NPC186418
0.8106 Intermediate Similarity NPC52277
0.8106 Intermediate Similarity NPC177035
0.8092 Intermediate Similarity NPC470881
0.8092 Intermediate Similarity NPC188555
0.8092 Intermediate Similarity NPC130496
0.8088 Intermediate Similarity NPC471063
0.8077 Intermediate Similarity NPC303422
0.8077 Intermediate Similarity NPC165686
0.8077 Intermediate Similarity NPC85799
0.8077 Intermediate Similarity NPC26080
0.8074 Intermediate Similarity NPC157816
0.8074 Intermediate Similarity NPC60249
0.8074 Intermediate Similarity NPC246947
0.8074 Intermediate Similarity NPC189115
0.8074 Intermediate Similarity NPC469559
0.8074 Intermediate Similarity NPC475084
0.806 Intermediate Similarity NPC210478
0.8047 Intermediate Similarity NPC40377
0.8047 Intermediate Similarity NPC146540
0.803 Intermediate Similarity NPC238243
0.8029 Intermediate Similarity NPC476864
0.8029 Intermediate Similarity NPC476869
0.8029 Intermediate Similarity NPC476868
0.8029 Intermediate Similarity NPC476866
0.8015 Intermediate Similarity NPC115022
0.8015 Intermediate Similarity NPC46092
0.8015 Intermediate Similarity NPC478239
0.8015 Intermediate Similarity NPC470950
0.8015 Intermediate Similarity NPC185307
0.8015 Intermediate Similarity NPC294166
0.8015 Intermediate Similarity NPC252169
0.8 Intermediate Similarity NPC473412
0.8 Intermediate Similarity NPC121376
0.8 Intermediate Similarity NPC469698
0.8 Intermediate Similarity NPC186406
0.7985 Intermediate Similarity NPC156376
0.7984 Intermediate Similarity NPC97326
0.7971 Intermediate Similarity NPC125755
0.7971 Intermediate Similarity NPC476865
0.7971 Intermediate Similarity NPC276753
0.7971 Intermediate Similarity NPC205796
0.797 Intermediate Similarity NPC40664
0.797 Intermediate Similarity NPC157554
0.797 Intermediate Similarity NPC469383
0.797 Intermediate Similarity NPC138350
0.797 Intermediate Similarity NPC3293
0.797 Intermediate Similarity NPC197723
0.797 Intermediate Similarity NPC165482
0.7969 Intermediate Similarity NPC198798
0.7956 Intermediate Similarity NPC76176
0.7956 Intermediate Similarity NPC473045
0.7956 Intermediate Similarity NPC470235
0.7956 Intermediate Similarity NPC476867
0.7956 Intermediate Similarity NPC79429
0.7956 Intermediate Similarity NPC129417
0.7956 Intermediate Similarity NPC232228
0.7956 Intermediate Similarity NPC25292
0.7956 Intermediate Similarity NPC469313
0.7956 Intermediate Similarity NPC138227
0.7956 Intermediate Similarity NPC217635
0.7956 Intermediate Similarity NPC168579
0.7956 Intermediate Similarity NPC283995
0.7956 Intermediate Similarity NPC471667
0.7955 Intermediate Similarity NPC107478
0.7953 Intermediate Similarity NPC12308
0.7941 Intermediate Similarity NPC476356
0.7939 Intermediate Similarity NPC470270
0.7914 Intermediate Similarity NPC52740
0.791 Intermediate Similarity NPC195196
0.791 Intermediate Similarity NPC87777
0.791 Intermediate Similarity NPC262328
0.7907 Intermediate Similarity NPC72529
0.7899 Intermediate Similarity NPC161700
0.7899 Intermediate Similarity NPC22150
0.7899 Intermediate Similarity NPC43508
0.7899 Intermediate Similarity NPC279298
0.7899 Intermediate Similarity NPC475096
0.7899 Intermediate Similarity NPC38041
0.7899 Intermediate Similarity NPC469586
0.7899 Intermediate Similarity NPC18979
0.7899 Intermediate Similarity NPC476301
0.7899 Intermediate Similarity NPC277867
0.7895 Intermediate Similarity NPC79957
0.7895 Intermediate Similarity NPC320259
0.7883 Intermediate Similarity NPC473044
0.7883 Intermediate Similarity NPC278961
0.7883 Intermediate Similarity NPC37793
0.7883 Intermediate Similarity NPC113680
0.7881 Intermediate Similarity NPC276061
0.7881 Intermediate Similarity NPC474148
0.7876 Intermediate Similarity NPC314803
0.7869 Intermediate Similarity NPC175771
0.7868 Intermediate Similarity NPC472711
0.7868 Intermediate Similarity NPC471908
0.7863 Intermediate Similarity NPC475067
0.7857 Intermediate Similarity NPC116229
0.7852 Intermediate Similarity NPC226005
0.7851 Intermediate Similarity NPC313193
0.7846 Intermediate Similarity NPC5851
0.7846 Intermediate Similarity NPC86030
0.7842 Intermediate Similarity NPC112861
0.7842 Intermediate Similarity NPC190714
0.7842 Intermediate Similarity NPC199928
0.7842 Intermediate Similarity NPC99515
0.784 Intermediate Similarity NPC205850
0.7836 Intermediate Similarity NPC172818
0.7836 Intermediate Similarity NPC166180
0.7836 Intermediate Similarity NPC25695
0.7826 Intermediate Similarity NPC292443
0.7823 Intermediate Similarity NPC214289
0.782 Intermediate Similarity NPC471029
0.782 Intermediate Similarity NPC34456
0.7815 Intermediate Similarity NPC30563
0.781 Intermediate Similarity NPC477800
0.781 Intermediate Similarity NPC140502
0.781 Intermediate Similarity NPC477794

  Chemically structural similarity: II. Similar Clinical/Approved Drugs

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.

●  The left chart: Distribution of similarity level between NPC228907 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.56 or Top200).

Similarity Score Similarity Level Drug ID Developmental Stage
0.8378 Intermediate Similarity NPD291 Approved
0.8361 Intermediate Similarity NPD1091 Approved
0.819 Intermediate Similarity NPD556 Approved
0.7727 Intermediate Similarity NPD9365 Approved
0.7552 Intermediate Similarity NPD1653 Approved
0.7391 Intermediate Similarity NPD3454 Phase 3
0.7368 Intermediate Similarity NPD9296 Approved
0.7357 Intermediate Similarity NPD6674 Discontinued
0.7338 Intermediate Similarity NPD7266 Discontinued
0.7279 Intermediate Similarity NPD1612 Clinical (unspecified phase)
0.7279 Intermediate Similarity NPD1613 Approved
0.7273 Intermediate Similarity NPD9552 Approved
0.7273 Intermediate Similarity NPD290 Approved
0.7266 Intermediate Similarity NPD1357 Approved
0.7244 Intermediate Similarity NPD1408 Clinical (unspecified phase)
0.7231 Intermediate Similarity NPD3705 Approved
0.7222 Intermediate Similarity NPD191 Approved
0.7214 Intermediate Similarity NPD521 Clinical (unspecified phase)
0.7185 Intermediate Similarity NPD3027 Phase 3
0.712 Intermediate Similarity NPD7843 Approved
0.7111 Intermediate Similarity NPD3537 Clinical (unspecified phase)
0.7083 Intermediate Similarity NPD5058 Phase 3
0.7073 Intermediate Similarity NPD2684 Approved
0.7067 Intermediate Similarity NPD8455 Phase 2
0.7054 Intermediate Similarity NPD7534 Approved
0.7054 Intermediate Similarity NPD7533 Approved
0.7025 Intermediate Similarity NPD9501 Approved
0.7 Intermediate Similarity NPD1798 Approved
0.7 Intermediate Similarity NPD1797 Approved
0.6985 Remote Similarity NPD1529 Clinical (unspecified phase)
0.6962 Remote Similarity NPD7054 Approved
0.6953 Remote Similarity NPD7157 Approved
0.6918 Remote Similarity NPD7472 Approved
0.6918 Remote Similarity NPD7074 Phase 3
0.6912 Remote Similarity NPD1530 Clinical (unspecified phase)
0.6879 Remote Similarity NPD4538 Approved
0.6879 Remote Similarity NPD4536 Approved
0.6879 Remote Similarity NPD4537 Clinical (unspecified phase)
0.6846 Remote Similarity NPD1102 Approved
0.6846 Remote Similarity NPD1103 Approved
0.6831 Remote Similarity NPD5588 Approved
0.6831 Remote Similarity NPD5960 Phase 3
0.6818 Remote Similarity NPD4381 Clinical (unspecified phase)
0.6792 Remote Similarity NPD3818 Discontinued
0.679 Remote Similarity NPD7808 Phase 3
0.6788 Remote Similarity NPD2250 Discontinued
0.6783 Remote Similarity NPD9295 Approved
0.6774 Remote Similarity NPD968 Approved
0.677 Remote Similarity NPD6797 Phase 2
0.6765 Remote Similarity NPD3827 Clinical (unspecified phase)
0.6761 Remote Similarity NPD7097 Phase 1
0.6759 Remote Similarity NPD1652 Phase 2
0.6741 Remote Similarity NPD2983 Phase 2
0.6741 Remote Similarity NPD2982 Phase 2
0.6728 Remote Similarity NPD7251 Discontinued
0.6714 Remote Similarity NPD6233 Phase 2
0.6692 Remote Similarity NPD5126 Approved
0.6692 Remote Similarity NPD5125 Phase 3
0.6692 Remote Similarity NPD5846 Approved
0.6692 Remote Similarity NPD6516 Phase 2
0.6691 Remote Similarity NPD8651 Approved
0.6688 Remote Similarity NPD7199 Phase 2
0.6687 Remote Similarity NPD7228 Approved
0.6687 Remote Similarity NPD4338 Clinical (unspecified phase)
0.6667 Remote Similarity NPD2981 Phase 2
0.6667 Remote Similarity NPD1548 Phase 1
0.6667 Remote Similarity NPD2861 Phase 2
0.6667 Remote Similarity NPD37 Approved
0.6645 Remote Similarity NPD4965 Approved
0.6645 Remote Similarity NPD4966 Approved
0.6645 Remote Similarity NPD4967 Phase 2
0.6644 Remote Similarity NPD5698 Clinical (unspecified phase)
0.6641 Remote Similarity NPD228 Approved
0.6621 Remote Similarity NPD1375 Discontinued
0.662 Remote Similarity NPD1933 Approved
0.6619 Remote Similarity NPD4908 Phase 1
0.6618 Remote Similarity NPD3685 Discontinued
0.6594 Remote Similarity NPD5647 Approved
0.6593 Remote Similarity NPD1610 Phase 2
0.6577 Remote Similarity NPD6143 Clinical (unspecified phase)
0.6577 Remote Similarity NPD1774 Approved
0.6571 Remote Similarity NPD3179 Approved
0.6571 Remote Similarity NPD3180 Approved
0.6562 Remote Similarity NPD2673 Approved
0.6562 Remote Similarity NPD2671 Approved
0.6561 Remote Similarity NPD6234 Discontinued
0.6547 Remote Similarity NPD3018 Phase 2
0.6547 Remote Similarity NPD5266 Clinical (unspecified phase)
0.6543 Remote Similarity NPD7804 Clinical (unspecified phase)
0.6538 Remote Similarity NPD5283 Phase 1
0.6525 Remote Similarity NPD4907 Clinical (unspecified phase)
0.6525 Remote Similarity NPD6798 Discontinued
0.6524 Remote Similarity NPD7685 Pre-registration
0.6524 Remote Similarity NPD7240 Approved
0.6522 Remote Similarity NPD2082 Clinical (unspecified phase)
0.6522 Remote Similarity NPD6362 Approved
0.6519 Remote Similarity NPD155 Clinical (unspecified phase)
0.6503 Remote Similarity NPD4340 Discontinued
0.65 Remote Similarity NPD7184 Clinical (unspecified phase)
0.6496 Remote Similarity NPD4379 Clinical (unspecified phase)
0.6489 Remote Similarity NPD9299 Approved
0.6483 Remote Similarity NPD7033 Discontinued
0.646 Remote Similarity NPD6168 Clinical (unspecified phase)
0.646 Remote Similarity NPD6166 Phase 2
0.646 Remote Similarity NPD6167 Clinical (unspecified phase)
0.6458 Remote Similarity NPD2224 Approved
0.6458 Remote Similarity NPD2223 Approved
0.6458 Remote Similarity NPD6653 Approved
0.6457 Remote Similarity NPD1358 Approved
0.6452 Remote Similarity NPD3382 Approved
0.6452 Remote Similarity NPD3383 Approved
0.6452 Remote Similarity NPD1934 Approved
0.6452 Remote Similarity NPD3384 Approved
0.6447 Remote Similarity NPD2122 Discontinued
0.6443 Remote Similarity NPD2677 Approved
0.6439 Remote Similarity NPD6671 Approved
0.6438 Remote Similarity NPD3787 Discontinued
0.6433 Remote Similarity NPD4868 Clinical (unspecified phase)
0.6423 Remote Similarity NPD2235 Phase 2
0.6423 Remote Similarity NPD2231 Phase 2
0.6419 Remote Similarity NPD4237 Approved
0.6419 Remote Similarity NPD4236 Phase 3
0.6414 Remote Similarity NPD4978 Clinical (unspecified phase)
0.641 Remote Similarity NPD9094 Approved
0.641 Remote Similarity NPD2978 Approved
0.641 Remote Similarity NPD2977 Approved
0.6408 Remote Similarity NPD6410 Clinical (unspecified phase)
0.6408 Remote Similarity NPD6859 Clinical (unspecified phase)
0.6405 Remote Similarity NPD3687 Approved
0.6405 Remote Similarity NPD3686 Approved
0.6403 Remote Similarity NPD9549 Phase 2
0.6403 Remote Similarity NPD1049 Clinical (unspecified phase)
0.64 Remote Similarity NPD5756 Phase 2
0.6397 Remote Similarity NPD915 Approved
0.6395 Remote Similarity NPD5763 Approved
0.6395 Remote Similarity NPD5762 Approved
0.6389 Remote Similarity NPD5123 Clinical (unspecified phase)
0.6389 Remote Similarity NPD5124 Phase 1
0.6385 Remote Similarity NPD969 Suspended
0.6377 Remote Similarity NPD4749 Approved
0.6376 Remote Similarity NPD4535 Phase 3
0.6376 Remote Similarity NPD4628 Phase 3
0.6369 Remote Similarity NPD3817 Phase 2
0.6364 Remote Similarity NPD3530 Approved
0.6364 Remote Similarity NPD4062 Phase 3
0.6364 Remote Similarity NPD3532 Approved
0.6364 Remote Similarity NPD1726 Clinical (unspecified phase)
0.6364 Remote Similarity NPD3531 Approved
0.6351 Remote Similarity NPD2424 Discontinued
0.6347 Remote Similarity NPD8312 Approved
0.6347 Remote Similarity NPD8313 Approved
0.6343 Remote Similarity NPD5536 Phase 2
0.634 Remote Similarity NPD5403 Approved
0.6336 Remote Similarity NPD821 Approved
0.6336 Remote Similarity NPD5535 Approved
0.6333 Remote Similarity NPD6190 Approved
0.6331 Remote Similarity NPD3225 Approved
0.6325 Remote Similarity NPD6559 Discontinued
0.6324 Remote Similarity NPD1778 Approved
0.6319 Remote Similarity NPD3619 Clinical (unspecified phase)
0.6319 Remote Similarity NPD1558 Phase 1
0.6319 Remote Similarity NPD3620 Phase 2
0.6316 Remote Similarity NPD4123 Phase 3
0.6316 Remote Similarity NPD5401 Approved
0.6309 Remote Similarity NPD5177 Phase 3
0.6309 Remote Similarity NPD4162 Approved
0.6309 Remote Similarity NPD5061 Approved
0.6309 Remote Similarity NPD5062 Approved
0.6306 Remote Similarity NPD5772 Approved
0.6306 Remote Similarity NPD2393 Clinical (unspecified phase)
0.6306 Remote Similarity NPD5773 Approved
0.6294 Remote Similarity NPD6843 Phase 3
0.6294 Remote Similarity NPD6841 Approved
0.6294 Remote Similarity NPD6842 Approved
0.6291 Remote Similarity NPD3122 Phase 3
0.6289 Remote Similarity NPD7975 Clinical (unspecified phase)
0.6277 Remote Similarity NPD3496 Discontinued
0.6276 Remote Similarity NPD5735 Approved
0.6276 Remote Similarity NPD6355 Discontinued
0.6267 Remote Similarity NPD4110 Phase 3
0.6267 Remote Similarity NPD4109 Clinical (unspecified phase)
0.6259 Remote Similarity NPD4108 Discontinued
0.625 Remote Similarity NPD6382 Discontinued
0.625 Remote Similarity NPD3134 Approved
0.6241 Remote Similarity NPD558 Phase 2
0.6234 Remote Similarity NPD6980 Clinical (unspecified phase)
0.6232 Remote Similarity NPD776 Approved
0.6232 Remote Similarity NPD422 Phase 1
0.6224 Remote Similarity NPD4625 Phase 3
0.6224 Remote Similarity NPD7095 Approved
0.6218 Remote Similarity NPD4380 Phase 2
0.6218 Remote Similarity NPD4675 Approved
0.6218 Remote Similarity NPD4678 Approved
0.6212 Remote Similarity NPD769 Approved
0.6209 Remote Similarity NPD7004 Clinical (unspecified phase)
0.6207 Remote Similarity NPD4060 Phase 1
0.6207 Remote Similarity NPD5837 Clinical (unspecified phase)
0.6203 Remote Similarity NPD2801 Approved
0.6202 Remote Similarity NPD5374 Approved
0.6202 Remote Similarity NPD5373 Approved

  Bioactivity similarity: Similar Natural Products in NPASS

Bioactivity similarity was calculated based on bioactivity descriptors of compounds. The bioactivity descriptors were calculated by a recently developed AI algorithm Chemical Checker (CC) [Nature Biotechnology, 38:1087–1096, 2020; Nature Communications, 12:3932, 2021], which evaluated bioactivity similarities at five levels:
A: chemistry similarity;
B: biological targets similarity;
C: networks similarity;
D: cell-based bioactivity similarity;
E: similarity based on clinical data.

Those 5 categories of CC bioactivity descriptors were calculated and then subjected to manifold projection using UMAP algorithm, to project all NPs on a 2-Dimensional space. The current NP was highlighted with a small circle in the 2-D map. Below figures: left-to-right, A-to-E.

A: chemistry similarity
B: biological targets similarity
C: networks similarity
D: cell-based bioactivity similarity
E: similarity based on clinical data